
南美洲和中美洲中型制药市场到 2028 年的预测 - COVID-19 影响和区域分析 - 按类型(处方药和非处方药)、药物开发类型(内部和外包)、配方(片剂和胶囊、注射剂、喷雾剂和其他制剂)和治疗类别(心血管疾病、疼痛管理、糖尿病、癌症和其他病症)
No. of Pages: 121 | Report Code: BMIRE00026158 | Category: Life Sciences
No. of Pages: 121 | Report Code: BMIRE00026158 | Category: Life Sciences
南和南的中型制药市场中美洲预计将从2022年的243.0156亿美元增长到2028年的3111.817亿美元;预计 2022 年至 2028 年复合年增长率为 4.2%。
南部和南部地区中美洲中型制药市场分为巴西、阿根廷和南美其他地区。中美洲。在全球市场中,SAM 占据第二小的份额,2022 年为 24,301.56 百万美元。 SAM 市场的增长是由癌症患病率上升、老年人口增加、高血压发病率激增以及其他慢性病患病率不断上升推动的。疾病。南部和南部其他地区的中型制药市场中美洲分为秘鲁、智利、玻利维亚、厄瓜多尔和其他国家。根据 GLOBOCAN 2020,前列腺癌是秘鲁人口癌症死亡的主要原因,年龄标准化死亡率 (ASMR) 为每 10 万人中 44.3 人。由于癌症患病率上升,预计该地区对肿瘤药物的需求将会上升,这将为中型制药公司创造利润丰厚的机会。
通过引入新功能和技术,南方和非洲的供应商中美洲中型制药市场可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动市场以良好的复合年增长率增长。
南和南中美洲中型制药
2028年市场收入及预测(百万美元)
<强>南&中美洲中型制药市场细分
南部和中部地区中美洲中型制药市场根据类型、药物开发类型、配方、治疗类别和国家进行细分。
根据类型,南部和南部地区中美洲中型药品市场分为处方药和非处方药。 2022年,场外交易领域占据更大的市场份额。根据药物开发类型,市场分为内部和外包。到 2022 年,外包细分市场将占据更大的市场份额。中美洲中型药品市场分为片剂和胶囊、注射剂、喷雾剂和其他制剂。平板电脑和胶囊细分市场在 2022 年占据最大的市场份额。根据治疗类别,市场分为心血管疾病、疼痛管理、糖尿病、癌症和其他疾病。到 2022 年,糖尿病细分市场占据最大的市场份额。中美洲中型制药市场分为巴西、阿根廷和南美其他地区。中美洲。 2022 年,巴西占据最大市场份额。
Alexion Pharmaceuticals, Inc.;博士健康公司;第一三共有限公司;远藤制药公司;马林克罗特;和 Sun Pharmaceutical Industries Ltd 是该地区中型制药市场的领先公司之一。
Strategic insights for South & Central America Mid-Size Pharmaceutical involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 24,301.56 Million |
Market Size by 2028 | US$ 31,118.17 Million |
Global CAGR (2022 - 2028) | 4.2% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South & Central America Mid-Size Pharmaceutical refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Mid-Size Pharmaceutical Market is valued at US$ 24,301.56 Million in 2022, it is projected to reach US$ 31,118.17 Million by 2028.
As per our report South & Central America Mid-Size Pharmaceutical Market, the market size is valued at US$ 24,301.56 Million in 2022, projecting it to reach US$ 31,118.17 Million by 2028. This translates to a CAGR of approximately 4.2% during the forecast period.
The South & Central America Mid-Size Pharmaceutical Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Mid-Size Pharmaceutical Market report:
The South & Central America Mid-Size Pharmaceutical Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Mid-Size Pharmaceutical Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Mid-Size Pharmaceutical Market value chain can benefit from the information contained in a comprehensive market report.